The U.S. Food and Drug Administration (FDA) has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method […]
Current and prospective clinical trial practitioners sell themselves and the future of the industry short if they view technology as a threat and not an opportunity, says long-time clinical trial […]
Rapid evolution in the science surrounding COVID-19 is going hand-in-hand with advances in biosimulation techniques that should increase the probability that vaccine candidates entering human trials are both safe and […]
Do the high hopes of many that a “silver bullet” treatment for COVID-19 is forthcoming any day now represent a red herring to the public where the complexities of clinical […]
As the world comes together to battle the COVID-19 pandemic, “people are rooting for clinical trials and the clinical trial professionals who make them possible,” says Pete Fronte, CEO at […]